US Stocks
/
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price

AMEX: CANF
$1.93
-$0.17 (-8.1%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Stock Performance

Open
$2.00
Prev. Close
$2.10
Circuit Range
N/A
Day Range
$1.91 - $2.00
Year Range
$0.17 - $10.39
Volume
1,235
Average Traded
$1.96

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price Today

As of 10 October 2026, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price is $1.93. The stock opened at $2.00, compared to its previous close of $2.10. During today's trading session, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price traded between $1.91 and $2.00, with an average price of $1.96. Over the past 52 weeks, the stock has recorded a high of $10.39 and a low of $0.17. In terms of performance, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price has declined by 38.73% over the last six months and is up 360.62% on a year-on-year basis.

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price Chart

$1.91$2.00
L
Show Current Price
H

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.20
$1.93
-13.06%
Sep 2026
$3.20
$2.22
-35.75%
Aug 2026
$3.52
$3.46
+5.66%
Jul 2026
$4.89
$3.27
+14.34%
Jun 2026
$3.25
$2.86
-16.37%
May 2026
$3.04
$3.42
+8.57%
Apr 2026
$3.18
$3.15
+1.61%
Mar 2026
$4.83
$3.10
-35.01%
Feb 2026
$4.14
$4.77
+17.78%
Jan 2026
$0.19
$4.05
+1,935.18%
Dec 2025
$0.34
$0.20
-43.30%
Nov 2025
$0.41
$0.35
-16.23%

CANF Share Price FAQs

What is Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) share price today?

chevron-up
Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) share price today is $1.93 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) stock?

chevron-up
The 52 week high of Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) stock is $10.39, while the 52 week low is $0.17 as of 10 Oct '26.

What is the 5 year returns of CANF?

chevron-up
The 5 year returns of CANF is -87.30% as on 10 Oct '26.

What is the high & low stock price of CANF today?

chevron-up
CANF stock price hit a high of $2.00 and low of $1.91 as of 10 Oct '26.

Can I buy CANF shares in India?

chevron-up
Yes. You can buy CANF in India by opening an international trading account.